Resmed Inc (RMD)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NYSE
Market cap: $32.95B
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Latest financial period: June 30, 2026
Filed with the SEC: August 13, 2026
Estimated earnings date: October 29, 2026
Profit #180 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 26.5% | 27.1% | 25.8% | 24.8% |
Growth #834 of 1484 companies
Payout #400 of 1484 companies
Safety #21 of 1484 companies
Price #564 of 1484 companies
